This page shows Ecarx Holdings (ECXWW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue growth is masking a business where losses shrink through overhead cuts, not through better cash economics.
Between FY2023 and FY2025, revenue rose to$848M while operating margin improved to-6.5% . But gross margin fell to19.0% and free cash flow remained negative at-$107M , showing that lower overhead—not stronger unit economics—drove most of the accounting improvement, so reported progress has not yet become a self-funding operating model.
FY2025 gross profit was only
The balance sheet still carries a funding mismatch: the current ratio was 0.6x and equity remained negative at
Financial Health Signals
We are recalculating Ecarx Holdings's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.
Ecarx Holdings passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Ecarx Holdings generates $1.43 in operating cash flow (-$94.4M OCF vs -$66.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Ecarx Holdings earns $-2.3 in operating income for every $1 of interest expense (-$54.8M vs $23.8M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Ecarx Holdings generated $847.9M in revenue in fiscal year 2025. This represents an increase of 9.9% from the prior year.
Ecarx Holdings's EBITDA was -$34.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 65.9% from the prior year.
Ecarx Holdings reported -$66.0M in net income in fiscal year 2025. This represents an increase of 49.1% from the prior year.
Ecarx Holdings earned $-0.20 per diluted share (EPS) in fiscal year 2025. This represents an increase of 48.7% from the prior year.
Cash & Balance Sheet
Ecarx Holdings generated -$106.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 40.4% from the prior year.
Ecarx Holdings held $87.1M in cash against $0 in long-term debt as of fiscal year 2025.
Margins & Returns
Ecarx Holdings's gross margin was 19.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.7 percentage points from the prior year.
Ecarx Holdings's operating margin was -6.5% in fiscal year 2025, reflecting core business profitability. This is up 9.5 percentage points from the prior year.
Ecarx Holdings's net profit margin was -7.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 9.0 percentage points from the prior year.
Capital Allocation
Ecarx Holdings invested $123.3M in research and development in fiscal year 2025. This represents a decrease of 29.5% from the prior year.
Ecarx Holdings invested $12.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 23.5% from the prior year.
ECXWW Income Statement
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q4'22 |
|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A |
ECXWW Balance Sheet
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q4'22 |
|---|---|---|---|---|---|---|
| Total Assets | $662.4M+33.8% | $494.9M-3.8% | $514.3M-7.3% | $555.0M-7.7% | $601.1M-2.5% | $616.3M |
| Current Assets | $483.2M+25.2% | $385.8M-0.1% | $386.1M-4.8% | $405.5M-12.5% | $463.2M-2.6% | $475.7M |
| Cash & Equivalents | $87.1M+1.0% | $86.2M+94.8% | $44.3M-59.2% | $108.4M+35.0% | $80.3M-24.9% | $106.9M |
| Inventory | $62.3M+78.2% | $35.0M+9.8% | $31.9M+30.7% | $24.4M+7.6% | $22.6M+18.7% | $19.1M |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | $60.6M |
| Goodwill | $3.7M+2.6% | $3.6M+2.5% | $3.5M | N/A | N/A | N/A |
| Total Liabilities | $945.9M+19.7% | $790.2M+5.1% | $752.0M+0.4% | $749.0M+4.2% | $718.6M+11.9% | $642.0M |
| Current Liabilities | $823.0M+12.3% | $733.0M+4.9% | $698.6M+11.5% | $626.4M+5.5% | $593.7M+13.8% | $521.9M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$282.7M+3.8% | -$293.7M-22.5% | -$239.7M-20.7% | -$198.5M-53.0% | -$129.8M-405.1% | -$25.7M |
| Retained Earnings | -$1.2B+0.3% | -$1.2B-6.1% | -$1.1B-12.8% | -$996.4M-6.1% | -$939.5M-13.5% | -$828.0M |
ECXWW Cash Flow Statement
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q4'22 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A |
ECXWW Financial Ratios
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q4'22 |
|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | 0.59+0.1 | 0.53-0.0 | 0.55-0.1 | 0.65-0.1 | 0.78-0.1 | 0.91 |
| Debt-to-Equity | -3.35-0.7 | -2.69+0.4 | -3.14+0.6 | -3.77+1.8 | -5.54+19.5 | -24.99 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$282.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.59), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Frequently Asked Questions
What is Ecarx Holdings's annual revenue?
Ecarx Holdings (ECXWW) reported $847.9M in total revenue for fiscal year 2025. This represents a 9.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Ecarx Holdings's revenue growing?
Ecarx Holdings (ECXWW) revenue grew by 9.9% year-over-year, from $771.5M to $847.9M in fiscal year 2025.
Is Ecarx Holdings profitable?
No, Ecarx Holdings (ECXWW) reported a net income of -$66.0M in fiscal year 2025, with a net profit margin of -7.8%.
What is Ecarx Holdings's EBITDA?
Ecarx Holdings (ECXWW) had EBITDA of -$34.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Ecarx Holdings's gross margin?
Ecarx Holdings (ECXWW) had a gross margin of 19.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Ecarx Holdings's operating margin?
Ecarx Holdings (ECXWW) had an operating margin of -6.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Ecarx Holdings's net profit margin?
Ecarx Holdings (ECXWW) had a net profit margin of -7.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Ecarx Holdings's free cash flow?
Ecarx Holdings (ECXWW) generated -$106.6M in free cash flow during fiscal year 2025. This represents a -40.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Ecarx Holdings's operating cash flow?
Ecarx Holdings (ECXWW) generated -$94.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Ecarx Holdings's total assets?
Ecarx Holdings (ECXWW) had $662.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Ecarx Holdings's capital expenditures?
Ecarx Holdings (ECXWW) invested $12.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Ecarx Holdings spend on research and development?
Ecarx Holdings (ECXWW) invested $123.3M in research and development during fiscal year 2025.
What is Ecarx Holdings's current ratio?
Ecarx Holdings (ECXWW) had a current ratio of 0.59 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Ecarx Holdings's debt-to-equity ratio?
Ecarx Holdings (ECXWW) had a debt-to-equity ratio of -3.35 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Ecarx Holdings's return on assets (ROA)?
Ecarx Holdings (ECXWW) had a return on assets of -10.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Ecarx Holdings's cash runway?
Based on fiscal year 2025 data, Ecarx Holdings (ECXWW) had $87.1M in cash against an annual operating cash burn of $94.4M. This gives an estimated cash runway of approximately 11 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Ecarx Holdings's debt-to-equity ratio negative or unusual?
Ecarx Holdings (ECXWW) has negative shareholder equity of -$282.7M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Ecarx Holdings's Piotroski F-Score?
Ecarx Holdings (ECXWW) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Ecarx Holdings's earnings high quality?
Ecarx Holdings (ECXWW) has an earnings quality ratio of 1.43x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Ecarx Holdings cover its interest payments?
Ecarx Holdings (ECXWW) has an interest coverage ratio of -2.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.